购物车
您的购物车当前为空
别名 度司妥单抗, MEDI573
Dusigitumab (MEDI573) is a fully humanised monoclonal antibody targeting IGF1/IGF2, inhibiting IGF1/IGF2-induced IGF-1R phosphorylation with an IC₅₀ of 0.97/0.2 µg/mL, suitable for cancer research.

为众多的药物研发团队赋能,
让新药发现更简单!
Dusigitumab (MEDI573) is a fully humanised monoclonal antibody targeting IGF1/IGF2, inhibiting IGF1/IGF2-induced IGF-1R phosphorylation with an IC₅₀ of 0.97/0.2 µg/mL, suitable for cancer research.
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 2,480 | 现货 | |
| 5 mg | ¥ 5,860 | 现货 | |
| 10 mg | ¥ 7,890 | 现货 | |
| 25 mg | ¥ 11,700 | 现货 | |
| 50 mg | ¥ 15,800 | 现货 |
| 产品描述 | Dusigitumab(MEDI573)是一种靶向IGF1/IGF2的全人源化单克隆抗体,抑制IGF1/IGF2诱导的IGF-1R磷酸化,IC 50=0.97/0.2 µg/mL,可用于研究癌症。 |
| 别名 | 度司妥单抗, MEDI573 |
| 反应种属 | Human |
| 应用 | ELISA FCM Functional assay |
| 抗体种类 | Monoclonal |
| 内毒素 | <1.0 EU/mg |
| 偶联 | Unconjugated |
| 基因ID | |
| Uniprot ID | |
| 靶点 | IGF2 |
| 分子量 | 144.22 kDa |
| CAS No. | 1204390-13-5 |
| 颜色 | Transparent |
| 物理性状 | Liquid |
| 存储 | store at low temperature | store at -20°C | Shipping with blue ice/Shipping at ambient temperature. |
对于不同动物的给药剂量换算,您也可以参考 更多